Epidermolysis Bullosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa Intervention: Biological: FCX-007 (no generic name is established; see below for FCX-007 description) Sponsors: Fibrocell Technologies, Inc.; Castle Creek Pharmaceuticals, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2019 Category: Research Source Type: clinical trials
The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Conditions: Dystrophic Epidermolysis Bullosa; DEB - Dystrophic Epidermolysis Bullosa Intervention: Sponsors: Krystal Biotech, Inc.; Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2019 Category: Research Source Type: clinical trials
